Fig. 6.
LGL leukemia sera blocks Fas-induced apoptosis of leukemic LGLs.
PBMCs from patients with LGL leukemia were activated with PHA and IL-2, then incubated with CH11 antibody in the presence of 20% normal serum or patient's autologus serum.
LGL leukemia sera blocks Fas-induced apoptosis of leukemic LGLs.
PBMCs from patients with LGL leukemia were activated with PHA and IL-2, then incubated with CH11 antibody in the presence of 20% normal serum or patient's autologus serum.
